These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 38001637)

  • 41. Personalized treatment of patients with very early hepatocellular carcinoma.
    Vitale A; Peck-Radosavljevic M; Giannini EG; Vibert E; Sieghart W; Van Poucke S; Pawlik TM
    J Hepatol; 2017 Feb; 66(2):412-423. PubMed ID: 27677712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resection for hepatocellular carcinoma.
    Ramesh H
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S90-6. PubMed ID: 25755617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.
    Guglielmi A; Ruzzenente A; Conci S; Valdegamberi A; Vitali M; Bertuzzo F; De Angelis M; Mantovani G; Iacono C
    World J Gastroenterol; 2014 Jun; 20(24):7525-33. PubMed ID: 24976693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.
    Gosalia AJ; Martin P; Jones PD
    Gastroenterol Hepatol (N Y); 2017 Jul; 13(7):398-410. PubMed ID: 28867968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transplantation versus liver resection in patients with hepatocellular carcinoma.
    Kow AWC
    Transl Gastroenterol Hepatol; 2019; 4():33. PubMed ID: 31231700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma.
    Zhang EL; Liang BY; Chen XP; Huang ZY
    World J Surg Oncol; 2015 Apr; 13():148. PubMed ID: 25879526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes.
    Koza A; Bhogal RH; Fotiadis N; Mavroeidis VK
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver transplantation for hepatocellular carcinoma: a surgical perspective.
    Fortune BE; Umman V; Gilliland T; Emre S
    J Clin Gastroenterol; 2013 Jul; 47 Suppl():S37-42. PubMed ID: 23632344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review.
    Muhammad H; Tehreem A; Ting PS; Gurakar M; Li SY; Simsek C; Alqahtani SA; Kim AK; Kohli R; Gurakar A
    J Clin Transl Hepatol; 2021 Oct; 9(5):738-748. PubMed ID: 34722189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on Locoregional Therapies for Liver Cancer: Radiation Segmentectomy.
    Dadrass F; Sher A; Kim E
    Curr Oncol; 2023 Nov; 30(12):10075-10084. PubMed ID: 38132366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma.
    Zane KE; Nagib PB; Jalil S; Mumtaz K; Makary MS
    World J Hepatol; 2022 May; 14(5):885-895. PubMed ID: 35721283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical Resection of a Recurrent Hepatocellular Carcinoma with Portal Vein Thrombosis: Is It a Good Treatment Option? A Case Report and Systematic Review of the Literature.
    Sena G; Paglione D; Gallo G; Goglia M; Osso M; Nardo B
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of hepatocellular carcinoma: beyond international guidelines.
    Colombo M; Sangiovanni A
    Liver Int; 2015 Jan; 35 Suppl 1():129-38. PubMed ID: 25529098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
    Gish RG; Finn RS; Marrero JA
    Gastroenterol Hepatol (N Y); 2013 Apr; 9(4 Suppl 2):1-24. PubMed ID: 24872793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review.
    He ZX; Xiang P; Gong JP; Cheng NS; Zhang W
    Ther Clin Risk Manag; 2016; 12():295-303. PubMed ID: 26966370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current surgical treatment strategies for hepatocellular carcinoma in North America.
    Khan AS; Fowler KJ; Chapman WC
    World J Gastroenterol; 2014 Nov; 20(41):15007-17. PubMed ID: 25386049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Operative therapy of hepatocellular carcinoma].
    Farkas SA; Schlitt HJ
    Radiologe; 2014 Jul; 54(7):673-8. PubMed ID: 25047523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus.
    Luo F; Li M; Ding J; Zheng S
    Front Oncol; 2021; 11():635731. PubMed ID: 34631513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.